awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
Graphs
1
Q28083296-3657AA25-AA03-48D3-9C86-A4ACFC2E8F6E
Q28083296-3657AA25-AA03-48D3-9C86-A4ACFC2E8F6E
BestRank
Statement
http://www.wikidata.org/entity/statement/Q28083296-3657AA25-AA03-48D3-9C86-A4ACFC2E8F6E
CD19-Targeted T Cells for Hematologic Malignancies: Clinical Experience to Date
P2860
Q28083296-3657AA25-AA03-48D3-9C86-A4ACFC2E8F6E
BestRank
Statement
http://www.wikidata.org/entity/statement/Q28083296-3657AA25-AA03-48D3-9C86-A4ACFC2E8F6E
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
3f2c08baff9e8d3690127f46db344bea98d42203
P2860
Chemotherapy-refractory diffuse large B-cell lymphoma and indolent B-cell malignancies can be effectively treated with autologous T cells expressing an anti-CD19 chimeric antigen receptor.